DK0614616T3 - Præparat til behandling af patienter med leversygdomme - Google Patents

Præparat til behandling af patienter med leversygdomme

Info

Publication number
DK0614616T3
DK0614616T3 DK94103163T DK94103163T DK0614616T3 DK 0614616 T3 DK0614616 T3 DK 0614616T3 DK 94103163 T DK94103163 T DK 94103163T DK 94103163 T DK94103163 T DK 94103163T DK 0614616 T3 DK0614616 T3 DK 0614616T3
Authority
DK
Denmark
Prior art keywords
composition
patients
preparation
treatment
ready
Prior art date
Application number
DK94103163T
Other languages
Danish (da)
English (en)
Inventor
Eric Leopold
Dirk H Montagne
Susan L Trimbo
Guy Vaussard
Ahmad Reza Kamarei
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of DK0614616T3 publication Critical patent/DK0614616T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94103163T 1993-03-09 1994-03-03 Præparat til behandling af patienter med leversygdomme DK0614616T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/028,373 US5571783A (en) 1993-03-09 1993-03-09 Composition and method for treating patients with hepatic disease

Publications (1)

Publication Number Publication Date
DK0614616T3 true DK0614616T3 (da) 2002-01-14

Family

ID=21843089

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94103163T DK0614616T3 (da) 1993-03-09 1994-03-03 Præparat til behandling af patienter med leversygdomme

Country Status (10)

Country Link
US (1) US5571783A (pt)
EP (1) EP0614616B1 (pt)
JP (1) JPH0748270A (pt)
AT (1) ATE209864T1 (pt)
AU (1) AU5763094A (pt)
CA (1) CA2116947A1 (pt)
DE (1) DE69429297T2 (pt)
DK (1) DK0614616T3 (pt)
ES (1) ES2167338T3 (pt)
PT (1) PT614616E (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9419345D0 (en) * 1994-09-26 1994-11-09 Sandoz Nutrition Ltd Organic compounds
US5589468A (en) * 1995-01-13 1996-12-31 Clintec Nutrition Co. Method for providing nutrition to elderly patients
HUP9800049A3 (en) * 1995-02-23 1999-01-28 Novartis Nutrition Ag Amino acid compositions and use thereof in clinical nutrition, and use of the said amino acids for preparing pharmaceutical compns. for the diminution of tnf
US5656608B1 (en) * 1995-02-23 2000-09-26 Novartis Nutrition Ltd Amino acid compositions and methods of treatment using same
GB9512100D0 (en) * 1995-06-14 1995-08-09 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
CA2173780A1 (en) * 1995-06-01 1996-12-02 Randy Grote Method for providing nutrition in a variety of compositional forms
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
JPH09194364A (ja) * 1996-01-22 1997-07-29 Snow Brand Milk Prod Co Ltd ビタミンａ吸収促進剤
WO1997038593A1 (en) * 1996-04-12 1997-10-23 Beth Israel Deaconess Medical Center, Inc. Diabetic supplement bar
US5866555A (en) * 1997-03-12 1999-02-02 Beth Israel Deaconess Medical Center Diabetic supplement bar
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
IT1291126B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine
ES2132021B1 (es) * 1997-05-28 2000-02-16 Riera Simon Schwartz Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas.
FR2765481B1 (fr) * 1997-07-07 2000-12-08 Jacques Bogart Sa Complexe amino-lipidique vitamine
US20040022827A1 (en) * 1997-09-30 2004-02-05 Chugai Seiyaku Kabusiki Kaisha Remedy for hepatopathy
JP2004527501A (ja) 2001-03-05 2004-09-09 ピー． アーネスト，スティーヴン 経腸処方
ATE369045T1 (de) * 2001-11-26 2007-08-15 Nestec Sa Lagerstabiles nahrungsmittelprodukt enthaltend molkenprotein, verfahren zu seiner herstellung und verwendung
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
AU2002367129A1 (en) * 2001-12-25 2003-07-15 Ajinomoto Co., Inc. Organ fibrosis inhibitors
JP5041664B2 (ja) * 2002-06-21 2012-10-03 ロレアル 脱毛症を治療するためのタウリンの利用
JPWO2004019928A1 (ja) * 2002-08-30 2005-12-15 味の素株式会社 肝疾患治療剤
US20040219188A1 (en) * 2003-05-02 2004-11-04 Comer Gail M. Composition and methods for nutritional management of patients with hepatic disease
US7256202B2 (en) * 2003-12-31 2007-08-14 Halow George M Composition and method for treatment of hepatic encephalopathy
US20060089412A1 (en) * 2004-10-18 2006-04-27 Ajinomoto Co. Inc. Pharmaceutical composition for the treatment of non-alcoholic fatty liver disease
AU2005308622B2 (en) 2004-11-26 2012-08-02 Ucl Business Plc Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
JP2006241140A (ja) * 2005-02-01 2006-09-14 Otsuka Pharmaceut Factory Inc 肝疾患用栄養組成物
NZ569235A (en) * 2005-12-15 2011-12-22 Nestec Sa Compositions and methods for preserving brain function using medium chain triglycerides
EP2363028A1 (en) * 2006-03-23 2011-09-07 Nestec S.A. High-calorie nutritional supplement
US20090092657A1 (en) * 2007-10-09 2009-04-09 Douglas Burke Amino acid combinant omega oil aphrodisiac
AU2009268742C1 (en) * 2008-07-07 2013-11-28 Pentec Health, Inc. Nutritive compositions and methods of using same
NZ619235A (en) * 2009-04-03 2015-06-26 Ocera Therapeutics Inc L-ornithine phenyl acetate and methods of making thereof
EP3517110A1 (en) 2009-06-08 2019-07-31 UCL Business PLC Treatment of inflammation using l-ornithine phenylacetate
CN102858192A (zh) * 2009-12-18 2013-01-02 斯托克里-丰康普公司 蛋白质恢复饮料
AU2010337355A1 (en) * 2010-01-04 2012-07-26 Pentec Health, Inc. Nutritive compositions and methods of using same
CA2801208C (en) 2010-06-28 2016-10-04 Nestec S.A. Hypocaloric, high protein nutritional compositions and methods of using same
KR101213825B1 (ko) 2010-07-16 2012-12-18 서울대학교산학협력단 세린을 유효성분으로 함유하는 지방간 질환의 예방 및 치료용 조성물
WO2012048043A1 (en) 2010-10-06 2012-04-12 Ocera Therapeutics, Inc. Methods of making l-ornithine phenyl acetate
US20210176999A1 (en) 2011-04-17 2021-06-17 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
WO2013133691A1 (en) * 2012-03-09 2013-09-12 N.V. Nutricia Liquid nutritional composition comprising free amino acids
WO2016085887A1 (en) 2014-11-24 2016-06-02 Ucl Business Plc Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
WO2017031131A1 (en) 2015-08-18 2017-02-23 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CA3063134A1 (en) 2017-05-11 2018-11-15 Ocera Therapeutics, Inc. Processes of making l-ornithine phenylacetate
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
MA52971A (fr) 2018-06-20 2021-04-28 Axcella Health Inc Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697287A (en) * 1969-01-28 1972-10-10 Morton Norwich Products Inc Amino acid food composition
US3698912A (en) * 1969-07-01 1972-10-17 Morton Norwich Products Inc Process for making nutrient composition
US3773930A (en) * 1971-03-23 1973-11-20 Johnson & Johnson Amino acid composition
IT987278B (it) * 1973-05-11 1975-02-20 Snam Progetti Procedimento per la preparazione di l carbamil ammino acidi e dei corrispondenti l amminoacidi
US3920838A (en) * 1973-09-04 1975-11-18 Flatt Jean Pierre Amino acid therapy
GB1511302A (en) * 1974-04-15 1978-05-17 Univ Johns Hopkins Pharmaceutical compositions comprising amino acid analogues
US4100161A (en) * 1974-04-15 1978-07-11 The Johns Hopkins University Promotion of protein synthesis and suppression of urea formation in the body by keto analogs of essential amino acids
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same
US4098910A (en) * 1975-02-19 1978-07-04 International Flavors & Fragrances Inc. Flavoring with certain 3-furyl alkyl disulfides
US4053589A (en) * 1975-11-24 1977-10-11 Control Drug Inc. Method of treating nutritional deficiency during cardiac cachexia, diabetes, hypoglycemia, gastroenterology, lipid, cell glycogen and keratin-related skin conditions and alcoholism
US4025650A (en) * 1975-11-24 1977-05-24 Control Drug, Inc. Method and composition for preventing nutritional deficiency
US4124448A (en) * 1976-04-09 1978-11-07 The Regents Of The University Of Minnesota Process for the large scale production of human growth hormone by serial secondary suspension culture
US4288546A (en) * 1976-04-09 1981-09-08 The Regents Of The University Of Minnesota Process for the large scale production of pituitary hormones by serial secondary suspension culture
US4082613A (en) * 1976-04-23 1978-04-04 The Regents Of The University Of Minnesota Process for the production of insulin by genetically transformed fungal cells
US4288542A (en) * 1976-04-30 1981-09-08 The Upjohn Company Radioenzymatic assay of catecholamines
GB1592791A (en) * 1977-01-07 1981-07-08 Radiochemical Centre Ltd Selenium- or tellurium-containing bile acids and derivatives thereof
DE2750159C3 (de) * 1977-11-09 1980-05-22 Lentia Gmbh, Chem. U. Pharm. Erzeugnisse - Industriebedarf, 8000 Muenchen Infusionslösung zur Behandlung von hepatischer Encephalopathie und ein Verfahren zu deren Herstellung
US4320146A (en) * 1978-03-17 1982-03-16 The Johns Hopkins University Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids
JPS5536457A (en) * 1978-09-08 1980-03-14 Ajinomoto Co Inc Amino acid infusion
JPS5564512A (en) * 1978-11-11 1980-05-15 Kanebo Ltd Cosmetic composition of oil-in-water emulsion
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4352814A (en) * 1979-04-18 1982-10-05 The Johns Hopkins University Treatment of hepatic and renal disorders with mixed salts of essential or semi-essential amino acids and nitrogen-free analogs
US4254103A (en) * 1979-06-08 1981-03-03 Institul de Cercetari Chimicofarmaceutice Hepatoprotector Factor (HF) and method of treatment
US4216065A (en) * 1979-06-18 1980-08-05 University Of Delaware Bio-selective electrode probes using tissue slices
US4252822A (en) * 1979-12-26 1981-02-24 Children's Hospital Medical Center Method for treating phenylketonuria
USRE30753E (en) * 1980-01-07 1981-09-29 The Regents Of The University Of Minnesota Process for the large scale production of human growth hormone by serial secondary suspension culture
US4284647A (en) * 1980-03-31 1981-08-18 The Johns Hopkins University Process for waste nitrogen removal
JPS5729949A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination of sugar branch related to cancer and diagnostic technique of cancer
JPS5852634B2 (ja) * 1980-12-05 1983-11-24 株式会社林原生物化学研究所 ウロキナ−ゼの製造法
US4529543A (en) * 1981-02-24 1985-07-16 Newport Pharmaceuticals International Hepatosin
US4898879A (en) * 1981-06-29 1990-02-06 Baxter International Inc. Nurtitional composition for management of hepatic failure
JPS58126767A (ja) * 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
FR2556594B1 (fr) * 1983-12-20 1988-09-09 Synthelabo Solutions d'acides amines
CH658165A5 (fr) * 1984-01-04 1986-10-31 Nestle Sa Produit alimentaire efficace dans le traitement de la lepre.
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4704394A (en) * 1984-04-25 1987-11-03 Technology Unlimited, Inc. Treatment for hyperactivity
US4687782A (en) * 1984-12-10 1987-08-18 Nutri-Fuels Systems, Inc. Nutritional composition for enhancing skeletal muscle adaptation to exercise training
DE3521226A1 (de) * 1985-02-08 1986-08-14 Hoechst Ag, 6230 Frankfurt Gene fuer biologisch aktive proteine
JPH0667831B2 (ja) * 1986-01-13 1994-08-31 森永乳業株式会社 肝物質合成機能障害改善用のアミノ酸組成物
US4863898A (en) * 1986-02-06 1989-09-05 Albion International, Inc. Amino acid chelated compositions for delivery to specific biological tissue sites
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5053387A (en) * 1987-02-20 1991-10-01 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
US4780309A (en) * 1987-06-16 1988-10-25 Warner-Lambert Company Edible aerosol foam compositions and method of preparing same
CA1333471C (en) * 1988-04-29 1994-12-13 Gustavo Bounous Whey protein concentrate as food supplement
JPH02145170A (ja) * 1988-11-29 1990-06-04 Nippon Oil & Fats Co Ltd 液状蛋白補助食品
US5221668A (en) * 1992-02-26 1993-06-22 Abbott Laboratories Nutritional product for trauma and surgery patients

Also Published As

Publication number Publication date
EP0614616A3 (en) 1995-07-26
DE69429297T2 (de) 2002-10-24
US5571783A (en) 1996-11-05
DE69429297D1 (de) 2002-01-17
PT614616E (pt) 2002-04-29
AU5763094A (en) 1994-09-15
ATE209864T1 (de) 2001-12-15
JPH0748270A (ja) 1995-02-21
EP0614616A2 (en) 1994-09-14
CA2116947A1 (en) 1994-09-10
EP0614616B1 (en) 2001-12-05
ES2167338T3 (es) 2002-05-16

Similar Documents

Publication Publication Date Title
DK0614616T3 (da) Præparat til behandling af patienter med leversygdomme
DK0567433T3 (da) Oralt indtagelige ernæringspræparater med forbedret smag
CA2054358A1 (en) High acid nutritional formulations
ATE215320T1 (de) Nahrungszusammensetzungen in verschiedenen formen
IL79462A0 (en) Bactericidal formulations containing quinolonecarboxylic acids and derivatives thereof for use in veterinary medicine
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
SG46307A1 (en) New pyrazine derivatives the preparation and use thereof
NZ242233A (en) Medicaments containing micronised dihydro-4-(3,5-di-t-butyl-4-hydroxy benzylidene)-2-methyl-2h-1,2-oxazin-3(4h)-one
ES2106096T3 (es) Procedimiento para asegurar glutation intracelular adecuado en el tejido.
AU8230187A (en) N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
DE69430416T2 (de) Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
DK0569393T3 (da) Derivater af dicarboxylsyrer med 6-12 carbonatomer og anvendelse af disse derivater og carboxylsyrer alene ved fremstillingen af farmaceutiske præparater til enderal og parenteral ernæring
NO170011C (no) Analogifremgangsmaate til fremstilling av propanolaminderivater
NO894083D0 (no) Framsoeytiske blandinger for behandling av adrenoleukodystrophy.
FI964535A0 (fi) Ravinnevalmiste
JPS6438023A (en) Unshakable specific drug for burn embrocation for external use
MX9605829A (es) Inhibicion de la union del h. influenzae a celulas humanas.